3CT 2024 – Critical Care Clinical Trialists Workshop
3CT 2024 – Critical Care Clinical Trialists Workshop13-15 June| Wahsington DC, USA Vist the 3CT website.
3CT 2024 – Critical Care Clinical Trialists Workshop13-15 June| Wahsington DC, USA Vist the 3CT website.
Hennigsdorf/Berlin (Germany), April 10, 2024 –AdrenoMed AG, the vascular integrity company, today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation to its lead product candidate enibarcimab, a first-in-class non-neutralizing
The article was published by David Wild, In Vivo, Citeline Commercial.
ISICEM 2024 – International Symposium on Intensive Care & Emergency Medicine18-21 March | Brussels, Belgium Meet the AdrenoMed team in Brussels Link to ISICEM
© 2024 AdrenoMed AG | Imprint/Impressum | Legal Notice/Datenschutzerklärung | Expanded Access Policy